img

Global Organ Transplant Immunosuppressant Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Organ Transplant Immunosuppressant Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
Organ Transplant Immunosuppressant Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Transplant Immunosuppressant Drugs market is projected to reach US$ 6403.3 million in 2034, increasing from US$ 5102 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2034. Demand from Bone Marrow Transplant and Heart Transplant are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Organ Transplant Immunosuppressant Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Organ Transplant Immunosuppressant Drugs key manufacturers include Roche, Sanofi, Astellas Pharma, Inc., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc. and Veloxis Pharmaceuticals, etc. Roche, Sanofi, Astellas Pharma, Inc. are top 3 players and held % sales share in total in 2022.
Organ Transplant Immunosuppressant Drugs can be divided into Antibodies, Antiproliferative Agents, Calcineurin Inhibitors and mTOR Inhibitors, etc. Antibodies is the mainstream product in the market, accounting for % sales share globally in 2022.
Organ Transplant Immunosuppressant Drugs is widely used in various fields, such as Bone Marrow Transplant, Heart Transplant, Kidney Transplant and Liver Transplant, etc. Bone Marrow Transplant provides greatest supports to the Organ Transplant Immunosuppressant Drugs industry development. In 2022, global % sales of Organ Transplant Immunosuppressant Drugs went into Bone Marrow Transplant filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Organ Transplant Immunosuppressant Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Sanofi
Astellas Pharma, Inc.
GlaxoSmithKline plc
Novartis AG
Pfizer, Inc.
Veloxis Pharmaceuticals
Segment by Type
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids

Segment by Application


Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Organ Transplant Immunosuppressant Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Organ Transplant Immunosuppressant Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Organ Transplant Immunosuppressant Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Organ Transplant Immunosuppressant Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Organ Transplant Immunosuppressant Drugs introduction, etc. Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Organ Transplant Immunosuppressant Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Organ Transplant Immunosuppressant Drugs Market Overview
1.1 Organ Transplant Immunosuppressant Drugs Product Overview
1.2 Organ Transplant Immunosuppressant Drugs Market Segment by Type
1.2.1 Antibodies
1.2.2 Antiproliferative Agents
1.2.3 Calcineurin Inhibitors
1.2.4 mTOR Inhibitors
1.2.5 Steroids
1.3 Global Organ Transplant Immunosuppressant Drugs Market Size by Type
1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Organ Transplant Immunosuppressant Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Organ Transplant Immunosuppressant Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Breakdown by Type (2018-2024)
2 Global Organ Transplant Immunosuppressant Drugs Market Competition by Company
2.1 Global Top Players by Organ Transplant Immunosuppressant Drugs Sales (2018-2024)
2.2 Global Top Players by Organ Transplant Immunosuppressant Drugs Revenue (2018-2024)
2.3 Global Top Players by Organ Transplant Immunosuppressant Drugs Price (2018-2024)
2.4 Global Top Manufacturers Organ Transplant Immunosuppressant Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Organ Transplant Immunosuppressant Drugs Market Competitive Situation and Trends
2.5.1 Organ Transplant Immunosuppressant Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Organ Transplant Immunosuppressant Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
2.8 Key Manufacturers Organ Transplant Immunosuppressant Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Organ Transplant Immunosuppressant Drugs Status and Outlook by Region
3.1 Global Organ Transplant Immunosuppressant Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Organ Transplant Immunosuppressant Drugs Historic Market Size by Region
3.2.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Organ Transplant Immunosuppressant Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Organ Transplant Immunosuppressant Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Region
3.3.1 Global Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Organ Transplant Immunosuppressant Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Organ Transplant Immunosuppressant Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Organ Transplant Immunosuppressant Drugs by Application
4.1 Organ Transplant Immunosuppressant Drugs Market Segment by Application
4.1.1 Bone Marrow Transplant
4.1.2 Heart Transplant
4.1.3 Kidney Transplant
4.1.4 Liver Transplant
4.1.5 Lung Transplant
4.2 Global Organ Transplant Immunosuppressant Drugs Market Size by Application
4.2.1 Global Organ Transplant Immunosuppressant Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Organ Transplant Immunosuppressant Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Organ Transplant Immunosuppressant Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Breakdown by Application (2018-2024)
5 North America Organ Transplant Immunosuppressant Drugs by Country
5.1 North America Organ Transplant Immunosuppressant Drugs Historic Market Size by Country
5.1.1 North America Organ Transplant Immunosuppressant Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2018-2024)
5.2 North America Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Country
5.2.1 North America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2024-2034)
6 Europe Organ Transplant Immunosuppressant Drugs by Country
6.1 Europe Organ Transplant Immunosuppressant Drugs Historic Market Size by Country
6.1.1 Europe Organ Transplant Immunosuppressant Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2018-2024)
6.2 Europe Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Country
6.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Organ Transplant Immunosuppressant Drugs by Region
7.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales in Value by Region (2024-2034)
8 Latin America Organ Transplant Immunosuppressant Drugs by Country
8.1 Latin America Organ Transplant Immunosuppressant Drugs Historic Market Size by Country
8.1.1 Latin America Organ Transplant Immunosuppressant Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Country
8.2.1 Latin America Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Organ Transplant Immunosuppressant Drugs by Country
9.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche Organ Transplant Immunosuppressant Drugs Products Offered
10.1.5 Roche Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Products Offered
10.2.5 Sanofi Recent Development
10.3 Astellas Pharma, Inc.
10.3.1 Astellas Pharma, Inc. Company Information
10.3.2 Astellas Pharma, Inc. Introduction and Business Overview
10.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
10.3.5 Astellas Pharma, Inc. Recent Development
10.4 GlaxoSmithKline plc
10.4.1 GlaxoSmithKline plc Company Information
10.4.2 GlaxoSmithKline plc Introduction and Business Overview
10.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Products Offered
10.4.5 GlaxoSmithKline plc Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Company Information
10.5.2 Novartis AG Introduction and Business Overview
10.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Products Offered
10.5.5 Novartis AG Recent Development
10.6 Pfizer, Inc.
10.6.1 Pfizer, Inc. Company Information
10.6.2 Pfizer, Inc. Introduction and Business Overview
10.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Products Offered
10.6.5 Pfizer, Inc. Recent Development
10.7 Veloxis Pharmaceuticals
10.7.1 Veloxis Pharmaceuticals Company Information
10.7.2 Veloxis Pharmaceuticals Introduction and Business Overview
10.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Products Offered
10.7.5 Veloxis Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Organ Transplant Immunosuppressant Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
11.4 Organ Transplant Immunosuppressant Drugs Market Dynamics
11.4.1 Organ Transplant Immunosuppressant Drugs Industry Trends
11.4.2 Organ Transplant Immunosuppressant Drugs Market Drivers
11.4.3 Organ Transplant Immunosuppressant Drugs Market Challenges
11.4.4 Organ Transplant Immunosuppressant Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Organ Transplant Immunosuppressant Drugs Distributors
12.3 Organ Transplant Immunosuppressant Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antibodies
Table 2. Major Company of Antiproliferative Agents
Table 3. Major Company of Calcineurin Inhibitors
Table 4. Major Company of mTOR Inhibitors
Table 5. Major Company of Steroids
Table 6. Global Organ Transplant Immunosuppressant Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (K Doses)
Table 8. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US& Million)
Table 10. Global Organ Transplant Immunosuppressant Drugs Market Share in Value by Type (2018-2024)
Table 11. Global Organ Transplant Immunosuppressant Drugs Price by Type (2018-2024) & (USD/ Dose)
Table 12. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2024-2034) & (K Doses)
Table 13. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type (2024-2034)
Table 16. Global Organ Transplant Immunosuppressant Drugs Price by Type (2024-2034) & (USD/ Dose)
Table 17. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (K Doses)
Table 18. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2018-2024)
Table 20. Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2018-2024)
Table 22. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2018-2024)
Table 24. Latin America Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2018-2024)
Table 26. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Organ Transplant Immunosuppressant Drugs Sales by Company (2018-2024) & (K Doses)
Table 28. Global Organ Transplant Immunosuppressant Drugs Sales Share by Company (2018-2024)
Table 29. Global Organ Transplant Immunosuppressant Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Company (2018-2024)
Table 31. Global Market Organ Transplant Immunosuppressant Drugs Price by Company (2018-2024) & (USD/ Dose)
Table 32. Global Organ Transplant Immunosuppressant Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Organ Transplant Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2022)
Table 35. Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market
Table 36. Key Manufacturers Organ Transplant Immunosuppressant Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Organ Transplant Immunosuppressant Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2018-2024) & (K Doses)
Table 40. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Region (2018-2024)
Table 43. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 44. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2024-2034) & (K Doses)
Table 45. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Region (2024-2034)
Table 48. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/ Dose) and Gross Margin (2024-2034)
Table 49. Global Organ Transplant Immunosuppressant Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (K Doses)
Table 51. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application (2018-2024)
Table 54. Global Organ Transplant Immunosuppressant Drugs Price by Application (2018-2024) & (USD/ Dose)
Table 55. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2024-2034) & (K Doses)
Table 56. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application (2024-2034)
Table 59. Global Organ Transplant Immunosuppressant Drugs Price by Application (2024-2034) & (USD/ Dose)
Table 60. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) (K Doses)
Table 61. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) (K Doses)
Table 63. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) (K Doses)
Table 65. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) (K Doses)
Table 67. Latin America Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) (K Doses)
Table 69. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (K Doses)
Table 71. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2018-2024)
Table 74. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (K Doses)
Table 75. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (K Doses)
Table 79. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (K Doses)
Table 83. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2018-2024) & (K Doses)
Table 87. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2024-2034) & (K Doses)
Table 91. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (K Doses)
Table 95. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (K Doses)
Table 99. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (K Doses)
Table 103. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (K Doses)
Table 107. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Country (2024-2034)
Table 110. Roche Company Information
Table 111. Roche Introduction and Business Overview
Table 112. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 113. Roche Organ Transplant Immunosuppressant Drugs Product
Table 114. Roche Recent Development
Table 115. Sanofi Company Information
Table 116. Sanofi Introduction and Business Overview
Table 117. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 118. Sanofi Organ Transplant Immunosuppressant Drugs Product
Table 119. Sanofi Recent Development
Table 120. Astellas Pharma, Inc. Company Information
Table 121. Astellas Pharma, Inc. Introduction and Business Overview
Table 122. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 123. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product
Table 124. Astellas Pharma, Inc. Recent Development
Table 125. GlaxoSmithKline plc Company Information
Table 126. GlaxoSmithKline plc Introduction and Business Overview
Table 127. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 128. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product
Table 129. GlaxoSmithKline plc Recent Development
Table 130. Novartis AG Company Information
Table 131. Novartis AG Introduction and Business Overview
Table 132. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 133. Novartis AG Organ Transplant Immunosuppressant Drugs Product
Table 134. Novartis AG Recent Development
Table 135. Pfizer, Inc. Company Information
Table 136. Pfizer, Inc. Introduction and Business Overview
Table 137. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 138. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product
Table 139. Pfizer, Inc. Recent Development
Table 140. Veloxis Pharmaceuticals Company Information
Table 141. Veloxis Pharmaceuticals Introduction and Business Overview
Table 142. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million USD), Price (USD/ Dose) and Gross Margin (2018-2024)
Table 143. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product
Table 144. Veloxis Pharmaceuticals Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Organ Transplant Immunosuppressant Drugs Market Trends
Table 148. Organ Transplant Immunosuppressant Drugs Market Drivers
Table 149. Organ Transplant Immunosuppressant Drugs Market Challenges
Table 150. Organ Transplant Immunosuppressant Drugs Market Restraints
Table 151. Organ Transplant Immunosuppressant Drugs Distributors List
Table 152. Organ Transplant Immunosuppressant Drugs Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Drugs Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Organ Transplant Immunosuppressant Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Organ Transplant Immunosuppressant Drugs Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Antibodies
Figure 6. Global Antibodies Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Antiproliferative Agents
Figure 8. Global Antiproliferative Agents Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of Calcineurin Inhibitors
Figure 10. Global Calcineurin Inhibitors Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Product Picture of mTOR Inhibitors
Figure 12. Global mTOR Inhibitors Sales YoY Growth (2018-2034) & (K Doses)
Figure 13. Product Picture of Steroids
Figure 14. Global Steroids Sales YoY Growth (2018-2034) & (K Doses)
Figure 15. Global Organ Transplant Immunosuppressant Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2022 & 2034
Figure 17. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type in 2022
Figure 18. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type in 2022
Figure 19. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type in 2022
Figure 23. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Immunosuppressant Drugs Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Immunosuppressant Drugs Revenue in 2022
Figure 29. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Bone Marrow Transplant
Figure 31. Global Bone Marrow Transplant Sales YoY Growth (2018-2034) & (K Doses)
Figure 32. Product Picture of Heart Transplant
Figure 33. Global Heart Transplant Sales YoY Growth (2018-2034) & (K Doses)
Figure 34. Product Picture of Kidney Transplant
Figure 35. Global Kidney Transplant Sales YoY Growth (2018-2034) & (K Doses)
Figure 36. Product Picture of Liver Transplant
Figure 37. Global Liver Transplant Sales YoY Growth (2018-2034) & (K Doses)
Figure 38. Product Picture of Lung Transplant
Figure 39. Global Lung Transplant Sales YoY Growth (2018-2034) & (K Doses)
Figure 40. Global Organ Transplant Immunosuppressant Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2022 & 2034
Figure 42. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application in 2022
Figure 43. North America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application in 2022
Figure 44. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application in 2022
Figure 48. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Organ Transplant Immunosuppressant Drugs Manufacturing Cost Structure
Figure 53. Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries